Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor pharmacokinetics and gene variation study in acute coronary syndrome
ChiCTR1900023176Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ticagrelor in acute coronary syndrome (ACS), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Plasma concentration, Gene detection and 1 more. Started May 2019; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR1900023176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023176.